Metraipolis › archive › dc_997f159929be
Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41155717
- DOI
- 10.3390/medicina61101730
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:44:25.921Z
- SHA-256 of the archived text
de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a- Stable URL of this page
https://metraipolis.com/documento/dc_997f159929be
How to cite
Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717 — Europe PMC (en), https://europepmc.org/article/MED/41155717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_997f159929be (Metraipolis archive dc_997f159929be, sha256 de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a)
BibTeX
@misc{dc997f159929be,
title = {Comparative Effectiveness of Clopidogrel Versus Aspirin for Primary Prevention in High-Risk Patients with Type 2 Diabetes: A Nationwide Propensity… — Europe PMC PMID:41155717},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41155717},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_997f159929be; sha256 de611640ff38e4ad6e8b9a138a99b940b59f2532d9b8edb4dc8d78315f61968a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155717. Agents can read the archived copy with the MCP tool read_document.